Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1285 to 1293 of 1293 entries
Sorted by: Best Match Show Resources per page
Malignant bone tumours in children: What's up?.

Journal of children's orthopaedics

Alves C.
PMID: 34476019
J Child Orthop. 2021 Aug 20;15(4):310-311. doi: 10.1302/1863-2548.15.210123.

No abstract available.

Cite
Alves C. Malignant bone tumours in children: What's up?. J Child Orthop. 2021;15(4):310-311doi: 10.1302/1863-2548.15.210123.
Alves, C. (2021). Malignant bone tumours in children: What's up?. Journal of children's orthopaedics, 15(4), 310-311. https://doi.org/10.1302/1863-2548.15.210123
Alves, Cristina. "Malignant bone tumours in children: What's up?." Journal of children's orthopaedics vol. 15,4 (2021): 310-311. doi: https://doi.org/10.1302/1863-2548.15.210123
Alves C. Malignant bone tumours in children: What's up?. J Child Orthop. 2021 Aug 20;15(4):310-311. doi: 10.1302/1863-2548.15.210123. PMID: 34476019; PMCID: PMC8381390.
Copy Download .nbib Format: NLM
The Therapeutic Efficacy of Dendrimer and Micelle Formulations for Breast Cancer Treatment.

Pharmaceutics

Alven S, Aderibigbe BA.
PMID: 33333778
Pharmaceutics. 2020 Dec 15;12(12). doi: 10.3390/pharmaceutics12121212.

Breast cancer is among the most common types of cancer in women and it is the cause of a high rate of mortality globally. The use of anticancer drugs is the standard treatment approach used for this type of...

Cite
Alven S, Aderibigbe BA. The Therapeutic Efficacy of Dendrimer and Micelle Formulations for Breast Cancer Treatment. Pharmaceutics. 2020;12(12)doi: 10.3390/pharmaceutics12121212.
Alven, S., & Aderibigbe, B. A. (2020). The Therapeutic Efficacy of Dendrimer and Micelle Formulations for Breast Cancer Treatment. Pharmaceutics, 12(12), . https://doi.org/10.3390/pharmaceutics12121212
Alven, Sibusiso, and Aderibigbe, Blessing Atim. "The Therapeutic Efficacy of Dendrimer and Micelle Formulations for Breast Cancer Treatment." Pharmaceutics vol. 12,12 (2020). doi: https://doi.org/10.3390/pharmaceutics12121212
Alven S, Aderibigbe BA. The Therapeutic Efficacy of Dendrimer and Micelle Formulations for Breast Cancer Treatment. Pharmaceutics. 2020 Dec 15;12(12). doi: 10.3390/pharmaceutics12121212. PMID: 33333778; PMCID: PMC7765183.
Copy Download .nbib Format: NLM
Subclinical Persistent Inflammation as risk factor for Crohn's Disease progression: findings from a prospective real-world study of 2 years.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

F M, D M, M P, B A, P L, I R, Ht S, P M, I M, A V, J C, J M, J R, C E, P S, F P, L C, M S, S D, C A, J A, S D, L PB, Cc D.
PMID: 34896644
Clin Gastroenterol Hepatol. 2021 Dec 09; doi: 10.1016/j.cgh.2021.12.004. Epub 2021 Dec 09.

BACKGROUND AND AIMS: Subclinical intestinal inflammation is common in Crohn's disease (CD). We aimed to explore its impact in the disease progression of infliximab-treated patients and the usefulness of fecal calprotectin (FC) and C-reactive protein (CRP) as surrogate minimally...

Cite
F M, D M, M P, et al. Subclinical Persistent Inflammation as risk factor for Crohn's Disease progression: findings from a prospective real-world study of 2 years. Clin Gastroenterol Hepatol. 2021;doi: 10.1016/j.cgh.2021.12.004.
F, M., D, M., M, P., B, A., P, L., I, R., Ht, S., P, M., I, M., A, V., J, C., J, M., J, R., C, E., P, S., F, P., L, C., M, S., S, D., C, A., J, A., S, D., L, P. B., Cc, D. (2021). Subclinical Persistent Inflammation as risk factor for Crohn's Disease progression: findings from a prospective real-world study of 2 years. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, . https://doi.org/10.1016/j.cgh.2021.12.004
F, Magro, et al. "Subclinical Persistent Inflammation as risk factor for Crohn's Disease progression: findings from a prospective real-world study of 2 years." Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association vol. (2021). doi: https://doi.org/10.1016/j.cgh.2021.12.004
F M, D M, M P, B A, P L, I R, Ht S, P M, I M, A V, J C, J M, J R, C E, P S, F P, L C, M S, S D, C A, J A, S D, L PB, Cc D. Subclinical Persistent Inflammation as risk factor for Crohn's Disease progression: findings from a prospective real-world study of 2 years. Clin Gastroenterol Hepatol. 2021 Dec 09; doi: 10.1016/j.cgh.2021.12.004. Epub 2021 Dec 09. PMID: 34896644.
Copy Download .nbib Format: NLM
An Astounding Percutaneous Endoscopic Gastrostomy Complication: A Pseudoaneurysm of Gastroduodenal Artery.

GE Portuguese journal of gastroenterology

João M, Alves S, Carvalheiro V, Areia M.
PMID: 34386560
GE Port J Gastroenterol. 2021 Jul;28(4):294-296. doi: 10.1159/000511463. Epub 2020 Nov 17.

No abstract available.

Cite
João M, Alves S, Carvalheiro V, et al. An Astounding Percutaneous Endoscopic Gastrostomy Complication: A Pseudoaneurysm of Gastroduodenal Artery. GE Port J Gastroenterol. 2020;28(4):294-296doi: 10.1159/000511463.
João, M., Alves, S., Carvalheiro, V., & Areia, M. (2021). An Astounding Percutaneous Endoscopic Gastrostomy Complication: A Pseudoaneurysm of Gastroduodenal Artery. GE Portuguese journal of gastroenterology, 28(4), 294-296. https://doi.org/10.1159/000511463
João, Mafalda, et al. "An Astounding Percutaneous Endoscopic Gastrostomy Complication: A Pseudoaneurysm of Gastroduodenal Artery." GE Portuguese journal of gastroenterology vol. 28,4 (2021): 294-296. doi: https://doi.org/10.1159/000511463
João M, Alves S, Carvalheiro V, Areia M. An Astounding Percutaneous Endoscopic Gastrostomy Complication: A Pseudoaneurysm of Gastroduodenal Artery. GE Port J Gastroenterol. 2021 Jul;28(4):294-296. doi: 10.1159/000511463. Epub 2020 Nov 17. PMID: 34386560; PMCID: PMC8314755.
Copy Download .nbib Format: NLM
Anti-Inflammatory and Antiproliferative Properties of Sweet Cherry Phenolic-Rich Extracts.

Molecules (Basel, Switzerland)

Gonçalves AC, Costa AR, Flores-Félix JD, Falcão A, Alves G, Silva LR.
PMID: 35011501
Molecules. 2022 Jan 02;27(1). doi: 10.3390/molecules27010268.

Cherries have largely been investigated due to their high content in phenolics in order to fully explore their health-promoting properties. Therefore, this work aimed to assess, for the first time, the anti-inflammatory potential of phenolic-targeted fractions of the

Cite
Gonçalves AC, Costa AR, Flores-Félix JD, et al. Anti-Inflammatory and Antiproliferative Properties of Sweet Cherry Phenolic-Rich Extracts. Molecules. 2022;27(1)doi: 10.3390/molecules27010268.
Gonçalves, A. C., Costa, A. R., Flores-Félix, J. D., Falcão, A., Alves, G., & Silva, L. R. (2022). Anti-Inflammatory and Antiproliferative Properties of Sweet Cherry Phenolic-Rich Extracts. Molecules (Basel, Switzerland), 27(1), . https://doi.org/10.3390/molecules27010268
Gonçalves, Ana C, et al. "Anti-Inflammatory and Antiproliferative Properties of Sweet Cherry Phenolic-Rich Extracts." Molecules (Basel, Switzerland) vol. 27,1 (2022). doi: https://doi.org/10.3390/molecules27010268
Gonçalves AC, Costa AR, Flores-Félix JD, Falcão A, Alves G, Silva LR. Anti-Inflammatory and Antiproliferative Properties of Sweet Cherry Phenolic-Rich Extracts. Molecules. 2022 Jan 02;27(1). doi: 10.3390/molecules27010268. PMID: 35011501; PMCID: PMC8747005.
Copy Download .nbib Format: NLM
Deciphering Promoter Hypermethylation of Genes Encoding for RASSF/Hippo Pathway Reveals the Poor Prognostic Factor of RASSF2 Gene Silencing in Colon Cancers.

Cancers

Riffet M, Eid Y, Faisant M, Fohlen A, Menahem B, Alves A, Dubois F, Levallet G, Bazille C.
PMID: 34885067
Cancers (Basel). 2021 Nov 26;13(23). doi: 10.3390/cancers13235957.

The aims of this study were to assess the frequency of promoter hypermethylation of the genes encoding the Ras associated domain family (RASSF)/Hippo pathway, as well as the impact on overall (OS) and progression-free survival (PFS) in a single-center...

Cite
Riffet M, Eid Y, Faisant M, et al. Deciphering Promoter Hypermethylation of Genes Encoding for RASSF/Hippo Pathway Reveals the Poor Prognostic Factor of RASSF2 Gene Silencing in Colon Cancers. Cancers (Basel). 2021;13(23)doi: 10.3390/cancers13235957.
Riffet, M., Eid, Y., Faisant, M., Fohlen, A., Menahem, B., Alves, A., Dubois, F., Levallet, G., & Bazille, C. (2021). Deciphering Promoter Hypermethylation of Genes Encoding for RASSF/Hippo Pathway Reveals the Poor Prognostic Factor of RASSF2 Gene Silencing in Colon Cancers. Cancers, 13(23), . https://doi.org/10.3390/cancers13235957
Riffet, Marc, et al. "Deciphering Promoter Hypermethylation of Genes Encoding for RASSF/Hippo Pathway Reveals the Poor Prognostic Factor of RASSF2 Gene Silencing in Colon Cancers." Cancers vol. 13,23 (2021). doi: https://doi.org/10.3390/cancers13235957
Riffet M, Eid Y, Faisant M, Fohlen A, Menahem B, Alves A, Dubois F, Levallet G, Bazille C. Deciphering Promoter Hypermethylation of Genes Encoding for RASSF/Hippo Pathway Reveals the Poor Prognostic Factor of RASSF2 Gene Silencing in Colon Cancers. Cancers (Basel). 2021 Nov 26;13(23). doi: 10.3390/cancers13235957. PMID: 34885067; PMCID: PMC8656858.
Copy Download .nbib Format: NLM
Design and modeling of a planar graphene structure as a terahertz cyclotron radiation source.

Scientific reports

Planillo J, Alves F.
PMID: 34354196
Sci Rep. 2021 Aug 05;11(1):15965. doi: 10.1038/s41598-021-95502-9.

With incredibly high carrier mobility and saturation velocity, graphene would be an ideal candidate for a miniaturized solid-state cyclotron radiation source. A planar semicircular graphene arc geometry was investigated for emission in the 0.5-1.5 THz range. Analytical studies, confirmed...

Cite
Planillo J, Alves F. Design and modeling of a planar graphene structure as a terahertz cyclotron radiation source. Sci Rep. 2021;11(1):15965doi: 10.1038/s41598-021-95502-9.
Planillo, J., & Alves, F. (2021). Design and modeling of a planar graphene structure as a terahertz cyclotron radiation source. Scientific reports, 11(1), 15965. https://doi.org/10.1038/s41598-021-95502-9
Planillo, Jordan, and Alves, Fabio. "Design and modeling of a planar graphene structure as a terahertz cyclotron radiation source." Scientific reports vol. 11,1 (2021): 15965. doi: https://doi.org/10.1038/s41598-021-95502-9
Planillo J, Alves F. Design and modeling of a planar graphene structure as a terahertz cyclotron radiation source. Sci Rep. 2021 Aug 05;11(1):15965. doi: 10.1038/s41598-021-95502-9. PMID: 34354196; PMCID: PMC8342439.
Copy Download .nbib Format: NLM
Transcriptomics and network analysis highlight potential pathways in the pathogenesis of pterygium.

Scientific reports

de Guimarães JA, Hounpke BW, Duarte B, Boso ALM, Viturino MGM, de Carvalho Baptista L, de Melo MB, Alves M.
PMID: 34997134
Sci Rep. 2022 Jan 07;12(1):286. doi: 10.1038/s41598-021-04248-x.

Pterygium is a common ocular surface condition frequently associated with irritative symptoms. The precise identity of its critical triggers as well as the hierarchical relationship between all the elements involved in the pathogenesis of this disease are not yet...

Cite
de Guimarães JA, Hounpke BW, Duarte B, et al. Transcriptomics and network analysis highlight potential pathways in the pathogenesis of pterygium. Sci Rep. 2022;12(1):286doi: 10.1038/s41598-021-04248-x.
de Guimarães, J. A., Hounpke, B. W., Duarte, B., Boso, A. L. M., Viturino, M. G. M., de Carvalho Baptista, L., de Melo, M. B., & Alves, M. (2022). Transcriptomics and network analysis highlight potential pathways in the pathogenesis of pterygium. Scientific reports, 12(1), 286. https://doi.org/10.1038/s41598-021-04248-x
de Guimarães, Juliana Albano, et al. "Transcriptomics and network analysis highlight potential pathways in the pathogenesis of pterygium." Scientific reports vol. 12,1 (2022): 286. doi: https://doi.org/10.1038/s41598-021-04248-x
de Guimarães JA, Hounpke BW, Duarte B, Boso ALM, Viturino MGM, de Carvalho Baptista L, de Melo MB, Alves M. Transcriptomics and network analysis highlight potential pathways in the pathogenesis of pterygium. Sci Rep. 2022 Jan 07;12(1):286. doi: 10.1038/s41598-021-04248-x. PMID: 34997134; PMCID: PMC8741985.
Copy Download .nbib Format: NLM
Impact of lung function decline on time to hospitalisation events in systemic sclerosis-associated interstitial lung disease (SSc-ILD): a joint model analysis.

Arthritis research & therapy

Kreuter M, Del Galdo F, Miede C, Khanna D, Wuyts WA, Hummers LK, Alves M, Schoof N, Stock C, Allanore Y.
PMID: 35012623
Arthritis Res Ther. 2022 Jan 10;24(1):19. doi: 10.1186/s13075-021-02710-9.

BACKGROUND: Interstitial lung disease (ILD) is a common organ manifestation in systemic sclerosis (SSc) and is the leading cause of death in patients with SSc. A decline in forced vital capacity (FVC) is an indicator of ILD progression and...

Cite
Kreuter M, Del Galdo F, Miede C, et al. Impact of lung function decline on time to hospitalisation events in systemic sclerosis-associated interstitial lung disease (SSc-ILD): a joint model analysis. Arthritis Res Ther. 2022;24(1):19doi: 10.1186/s13075-021-02710-9.
Kreuter, M., Del Galdo, F., Miede, C., Khanna, D., Wuyts, W. A., Hummers, L. K., Alves, M., Schoof, N., Stock, C., & Allanore, Y. (2022). Impact of lung function decline on time to hospitalisation events in systemic sclerosis-associated interstitial lung disease (SSc-ILD): a joint model analysis. Arthritis research & therapy, 24(1), 19. https://doi.org/10.1186/s13075-021-02710-9
Kreuter, Michael, et al. "Impact of lung function decline on time to hospitalisation events in systemic sclerosis-associated interstitial lung disease (SSc-ILD): a joint model analysis." Arthritis research & therapy vol. 24,1 (2022): 19. doi: https://doi.org/10.1186/s13075-021-02710-9
Kreuter M, Del Galdo F, Miede C, Khanna D, Wuyts WA, Hummers LK, Alves M, Schoof N, Stock C, Allanore Y. Impact of lung function decline on time to hospitalisation events in systemic sclerosis-associated interstitial lung disease (SSc-ILD): a joint model analysis. Arthritis Res Ther. 2022 Jan 10;24(1):19. doi: 10.1186/s13075-021-02710-9. PMID: 35012623; PMCID: PMC8751320.
Copy Download .nbib Format: NLM
Showing 1285 to 1293 of 1293 entries